Compare $CBIO vs $STTK | Chartloom

Compare

$CBIO vs $STTK

Crescent Biopharma Inc · Shattuck Labs Inc

CBIO

Crescent Biopharma Inc

STTK

Shattuck Labs Inc

Compare $CBIO vs $STTK

Comparing Crescent Biopharma Inc and Shattuck Labs Inc

CBIOCrescent Biopharma Inc

STTKShattuck Labs Inc

CBIOCrescent Biopharma Inc

Market cap

$532M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

34.6%

52W performance

23.6%

FCF yield

-28.9%

STTKShattuck Labs Inc

Market cap

$540M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-66.6%

YTD performance

60.9%

52W performance

149.8%

FCF yield

-7.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CBIO

STTK

Detailed metrics comparison

CBIO

Crescent Biopharma Inc

STTK

Shattuck Labs Inc

Market Cap

CBIO$532M

STTK$540M

Enterprise Value

CBIO$360M

STTK$476M

Price

CBIO$14.91

STTK$5.97

P/E Ratio

CBION/A

STTKN/A

P/S Ratio

CBIO44.76x

STTK539.51x

EV/Sales

CBIO30.32x

STTK476.21x

EV/EBITDA

CBIO0.00x

STTK0.00x

P/B Ratio

CBIO3.26x

STTK3.20x

P/FCF Ratio

CBION/A

STTKN/A

EV/FCF

CBIO-2.35x

STTK-11.55x

PEG Ratio

CBION/A

STTKN/A

Forward P/E (NTM)

CBION/A

STTKN/A

Forward P/S (NTM)

CBION/A

STTKN/A

Revenue (TTM)

CBIO$12M

STTK$1M

Revenue Growth (YoY)

CBION/A

STTK-66.6%

Forward Rev Growth

CBIO-15.7%

STTK118.7%

Gross Margin (TTM)

CBIO0.0%

STTK0.0%

Operating Margin (TTM)

CBIO0.0%

STTK0.0%

EBITDA Margin (TTM)

CBIO-1355.3%

STTK-5212.2%

Net Margin (TTM)

CBIO-1406.4%

STTK-5256.8%

FCF Margin (TTM)

CBIO-1292.8%

STTK-4124.0%

Net Income (TTM)

CBIO$-167M

STTK$-53M

FCF (TTM)

CBIO$-154M

STTK$-41M

EPS (TTM)

CBIO-$5.47

STTK-$0.41

ROE (TTM)

CBIO-10026.0%

STTK-4357.0%

ROA (TTM)

CBIO-8791.0%

STTK-4090.0%

ROIC (TTM)

CBIO-10026.0%

STTK-4357.0%

Cash

CBIO$172M

STTK$63M

Debt

CBIO$0

STTK$0

Net Cash/Debt

CBIO$172M

STTK$63M

Current Ratio (TTM)

CBIO9.66x

STTK27.59x

Quick Ratio (TTM)

CBIO9.26x

STTK26.94x

Debt/Equity (TTM)

CBIO0.00x

STTK0.00x

Debt/Assets (TTM)

CBIO0.0%

STTK0.0%

Interest Coverage (TTM)

CBION/A

STTKN/A

Net Debt/EBITDA (TTM)

CBIO0.00x

STTK0.00x

Beta

CBIO1.39

STTK0.98

52W Performance

CBIO23.6%

STTK149.8%

YTD Performance

CBIO34.6%

STTK60.9%

% from 52W High

CBIO-45.6%

STTK-28.3%

% from 52W Low

CBIO71.0%

STTK251.2%

Asset Turnover (TTM)

CBIO0.05x

STTK0.01x

FCF Yield (TTM)

CBIO-28.9%

STTK-7.6%

Earnings Yield (TTM)

CBIO-31.4%

STTK-9.7%

Dividend Yield (TTM)

CBION/A

STTKN/A

Rule of 40

CBIO-1,292.8

STTK-4,190.6

EV/GP/RG

CBION/A

STTKN/A

Ticker research

View CBIO research View STTK research

Metric	CBIO Crescent Biopharma Inc	STTK Shattuck Labs Inc
Market & Valuation
Market Cap	$532M	$540M
Enterprise Value	$360M	$476M
Price	$14.91	$5.97
P/E Ratio	N/A	N/A
P/S Ratio	44.76x	539.51x
EV/Sales	30.32x	476.21x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.26x	3.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.35x	-11.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$12M	$1M
Revenue Growth (YoY)	N/A	-66.6%
Forward Rev Growth	-15.7%	118.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1355.3%	-5212.2%
Net Margin (TTM)	-1406.4%	-5256.8%
FCF Margin (TTM)	-1292.8%	-4124.0%
Net Income (TTM)	$-167M	$-53M
FCF (TTM)	$-154M	$-41M
EPS (TTM)	-$5.47	-$0.41
ROE (TTM)	-10026.0%	-4357.0%
ROA (TTM)	-8791.0%	-4090.0%
ROIC (TTM)	-10026.0%	-4357.0%
Financial Health
Cash	$172M	$63M
Debt	$0	$0
Net Cash/Debt	$172M	$63M
Current Ratio (TTM)	9.66x	27.59x
Quick Ratio (TTM)	9.26x	26.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	0.98
52W Performance	23.6%	149.8%
YTD Performance	34.6%	60.9%
% from 52W High	-45.6%	-28.3%
% from 52W Low	71.0%	251.2%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.01x
FCF Yield (TTM)	-28.9%	-7.6%
Earnings Yield (TTM)	-31.4%	-9.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,292.8	-4,190.6
EV/GP/RG	N/A	N/A
Ticker research	View CBIO research	View STTK research

Valuation

P/S Ratio

CBIO

44.76x

STTK

539.51x

EV/FCF

STTK

-11.55x

CBIO

-2.35x

Growth & revenue

Revenue Growth TTM

STTK

-66.6%

Forward Revenue Growth

STTK

118.7%

CBIO

-15.7%

Profitability & performance

Gross Margin

CBIO

0.0%

STTK

0.0%

ROE

STTK

-4357.0%

CBIO

-10026.0%

FCF Yield %

STTK

-7.6%

CBIO

-28.9%

52-Week Performance

STTK

149.8%

CBIO

23.6%

Detailed metrics comparison

CBIO

Crescent Biopharma Inc

STTK

Shattuck Labs Inc

Market Cap

CBIO$532M

STTK$540M

Enterprise Value

CBIO$360M

STTK$476M

Price

CBIO$14.91

STTK$5.97

P/E Ratio

CBION/A

STTKN/A

P/S Ratio

CBIO44.76x

STTK539.51x

EV/Sales

CBIO30.32x

STTK476.21x

EV/EBITDA

CBIO0.00x

STTK0.00x

P/B Ratio

CBIO3.26x

STTK3.20x

P/FCF Ratio

CBION/A

STTKN/A

EV/FCF

CBIO-2.35x

STTK-11.55x

PEG Ratio

CBION/A

STTKN/A

Forward P/E (NTM)

CBION/A

STTKN/A

Forward P/S (NTM)

CBION/A

STTKN/A

Revenue (TTM)

CBIO$12M

STTK$1M

Revenue Growth (YoY)

CBION/A

STTK-66.6%

Forward Rev Growth

CBIO-15.7%

STTK118.7%

Gross Margin (TTM)

CBIO0.0%

STTK0.0%

Operating Margin (TTM)

CBIO0.0%

STTK0.0%

EBITDA Margin (TTM)

CBIO-1355.3%

STTK-5212.2%

Net Margin (TTM)

CBIO-1406.4%

STTK-5256.8%

FCF Margin (TTM)

CBIO-1292.8%

STTK-4124.0%

Net Income (TTM)

CBIO$-167M

STTK$-53M

FCF (TTM)

CBIO$-154M

STTK$-41M

EPS (TTM)

CBIO-$5.47

STTK-$0.41

ROE (TTM)

CBIO-10026.0%

STTK-4357.0%

ROA (TTM)

CBIO-8791.0%

STTK-4090.0%

ROIC (TTM)

CBIO-10026.0%

STTK-4357.0%

Cash

CBIO$172M

STTK$63M

Debt

CBIO$0

STTK$0

Net Cash/Debt

CBIO$172M

STTK$63M

Current Ratio (TTM)

CBIO9.66x

STTK27.59x

Quick Ratio (TTM)

CBIO9.26x

STTK26.94x

Debt/Equity (TTM)

CBIO0.00x

STTK0.00x

Debt/Assets (TTM)

CBIO0.0%

STTK0.0%

Interest Coverage (TTM)

CBION/A

STTKN/A

Net Debt/EBITDA (TTM)

CBIO0.00x

STTK0.00x

Beta

CBIO1.39

STTK0.98

52W Performance

CBIO23.6%

STTK149.8%

YTD Performance

CBIO34.6%

STTK60.9%

% from 52W High

CBIO-45.6%

STTK-28.3%

% from 52W Low

CBIO71.0%

STTK251.2%

Asset Turnover (TTM)

CBIO0.05x

STTK0.01x

FCF Yield (TTM)

CBIO-28.9%

STTK-7.6%

Earnings Yield (TTM)

CBIO-31.4%

STTK-9.7%

Dividend Yield (TTM)

CBION/A

STTKN/A

Rule of 40

CBIO-1,292.8

STTK-4,190.6

EV/GP/RG

CBION/A

STTKN/A

Ticker research

View CBIO research View STTK research

Metric	CBIO Crescent Biopharma Inc	STTK Shattuck Labs Inc
Market & Valuation
Market Cap	$532M	$540M
Enterprise Value	$360M	$476M
Price	$14.91	$5.97
P/E Ratio	N/A	N/A
P/S Ratio	44.76x	539.51x
EV/Sales	30.32x	476.21x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.26x	3.20x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.35x	-11.55x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$12M	$1M
Revenue Growth (YoY)	N/A	-66.6%
Forward Rev Growth	-15.7%	118.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1355.3%	-5212.2%
Net Margin (TTM)	-1406.4%	-5256.8%
FCF Margin (TTM)	-1292.8%	-4124.0%
Net Income (TTM)	$-167M	$-53M
FCF (TTM)	$-154M	$-41M
EPS (TTM)	-$5.47	-$0.41
ROE (TTM)	-10026.0%	-4357.0%
ROA (TTM)	-8791.0%	-4090.0%
ROIC (TTM)	-10026.0%	-4357.0%
Financial Health
Cash	$172M	$63M
Debt	$0	$0
Net Cash/Debt	$172M	$63M
Current Ratio (TTM)	9.66x	27.59x
Quick Ratio (TTM)	9.26x	26.94x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	0.98
52W Performance	23.6%	149.8%
YTD Performance	34.6%	60.9%
% from 52W High	-45.6%	-28.3%
% from 52W Low	71.0%	251.2%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.01x
FCF Yield (TTM)	-28.9%	-7.6%
Earnings Yield (TTM)	-31.4%	-9.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,292.8	-4,190.6
EV/GP/RG	N/A	N/A
Ticker research	View CBIO research	View STTK research